ZURA

Zura Bio Limited Class A Ordinary Shares

5.83

USD

ZURA Earnings Reports

Positive Surprise Ratio

ZURA beat 5 of 10 last estimates.

50%

Next Report

Date of Next Report

Mar 23, 2026

Estimate for Q4 25 (Revenue/ EPS)

-$0.20

Implied change from Q3 25 (Revenue/ EPS)

-4.76%

Implied change from Q4 24 (Revenue/ EPS)

+100.00%

Zura Bio Limited Class A Ordinary Shares earnings per share and revenue

On Nov 13, 2025, ZURA reported earnings of -0.21 USD per share (EPS) for Q3 25, missing the estimate of -0.18 USD, resulting in a -13.45% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -9.72% price change (close before vs. close after earnings).

Looking ahead to Q4 25, 9 analysts forecast an EPS of -0.20 USD, with revenue projected to reach -- USD, implying an decrease of -4.76% EPS, and increase of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Nurix Therapeutics, Inc. Common stock

Report Date

Jan 28, 2026 For Q4 25

Estimate

-$0.88

Actual

-$0.82

Surprise

+7.66%

Regeneron Pharmaceuticals Inc

Report Date

Jan 30, 2026 For Q4 25

Estimate

$10.84

Actual

$11.44

Surprise

+5.52%

Twist Bioscience Corporation Common Stock

Report Date

Feb 02, 2026 For Q1 26

Estimate

-$0.43

Actual

-$0.50

Surprise

-14.00%

FAQ

What were Zura Bio Limited Class A Ordinary Shares's earnings and revenue for the latest quarter Q3 2025?

For Q3 2025, Zura Bio Limited Class A Ordinary Shares reported EPS of -$0.21, missing estimates by -13.45%, and revenue of $0.00, 0% as expectations.

How did the market react to Zura Bio Limited Class A Ordinary Shares's Q3 2025 earnings?

The stock price moved down -9.72%, changed from $4.63 before the earnings release to $4.18 the day after.

When is Zura Bio Limited Class A Ordinary Shares expected to report next?

The next earning report is scheduled for Mar 23, 2026.

What are the forecasts for Zura Bio Limited Class A Ordinary Shares's next earnings report?

Based on 9 analysts, Zura Bio Limited Class A Ordinary Shares is expected to report EPS of -$0.20 and revenue of -- for Q4 2025.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.